v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net earnings $ 42,060 $ 63,788 $ 69,350
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities      
Depreciation and amortization 14,539 12,702 13,393
Right-of-use asset reduction 7,690 7,693 8,017
(Gain) loss on sale of property and equipment 1 10 141
Equity-based compensation expense 14,558 14,595 13,331
Deferred income taxes (6,744) (2,749) (7,183)
Inventory write-down 1,891 2,601 6,082
Changes in operating assets and liabilities, net of acquisitions:      
Inventories (2,118) 2,353 15,797
Prepaid expenses and other assets (2,871) 110 (3,304)
Accounts payable (1,269) (428) (2,656)
Other liabilities (6,745) (30,034) (9,066)
Net cash provided by (used in) operating activities 60,992 70,641 103,902
Cash flows from investing activities      
Proceeds from the settlement of net investment hedges 1,125 3,775 4,555
Payments for net investment hedge (870) (1,271) 0
Payments to acquire businesses, net of cash acquired (203,336) 0 (6,532)
Proceeds from sale of property and equipment 64 15 7
Purchases of property and equipment (10,073) (14,494) (10,400)
Net cash provided by (used in) investing activities (213,090) (11,975) (12,370)
Cash flows from financing activities      
Repurchase of common stock (9,444) (11,599) (25,382)
Borrowings on line of credit 23,687 1,542 11,000
Payments on line of credit (1,467) (750) (11,000)
Payments related to tax withholding for net-share settled equity awards (3,223) (3,092) (4,706)
Payments for contingent consideration 0 (338) 0
Net cash provided by (used in) financing activities 9,553 (14,237) (30,088)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (6,193) (2,503) (13,777)
Net increase (decrease) in cash, cash equivalents, and restricted cash (148,738) 41,926 47,667
Cash, cash equivalents, and restricted cash at beginning of period 333,246 291,320 243,653
Cash, cash equivalents, and restricted cash at end of period 184,508 333,246 291,320
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Cash and cash equivalents 181,768 330,420 288,420
Restricted cash included in other assets 2,740 2,826 2,900
Total cash, cash equivalents, and restricted cash 184,508 333,246 291,320
Cash paid during the period for:      
Interest 76 68 49
Income taxes 40,470 44,247 45,863
Cash received during the period for:      
Income tax refund 75 1,922 113
Non-cash investing and financing activities:      
Right-of-use assets obtained in exchange for lease obligations 12,463 5,699 5,641
Net working capital adjustment receivable 778 0 0
Accrued purchases of property and equipment 42 117 679
Contingent consideration given to acquire businesses 0 0 886
Accrued excise tax for repurchase of common stock $ 39 $ 54 $ 0

Source